新东方网>英语>英语学习>英语阅读>双语新闻>时政热点>正文

英语新闻:疫苗事件得到控制

2016-03-23 16:24

来源:China.org.cn

作者:

  最高检挂牌督办问题疫苗案 山东已控制37人 连日来,涉案价值高达5.7亿元的非法经营疫苗案持续引发关注。目前,官方公布的9家涉嫌虚构疫苗销售渠道的药品批发企业名单中,已有多家被查处。各地职能部门迅速排查整治,其中山东已控制37名涉案人员。

  Police in east China's Shandong Province have detained 37suspects implicated in a vaccine scandal that has shocked thenation and raised questions over vaccine safety.

  Shandong police announced last month that they had arrested a mother and daughter alleged tohave illegally sold improperly stored or expired vaccines worth more than 570 million yuan (88million U.S. dollars) across 20 provincial-level regions since 2011.

  Three pharmaceutical companies are being investigated by police, according to the work grouphandling the case.

  Of the three, Shandong Zhaoxin Bio-tech Co. has had its good supply practice (GSP) certificate forpharmaceutical products revoked and ordered to halt operations.

  The investigation involves 12 vaccines, 2 immune globulin and one therapeutic product.

  Meanwhile, the group has ordered a sweeping check-up of local vaccine makers, wholesalers andbuyers.

  China's drug regulator has identified nine vaccine wholesalers from six provinces suspected of filingfraudulent reports of buyers' identities.

  The China Food and Drug Administration said Tuesday that it had given local authorities untilFriday to find out who bought the vaccines.

  China's top drug regulator, health authorities and police on Monday issued a circular orderingdrug and health departments to trace the manufacturing source and to remove any of thesubstandard vaccines off the market as soon as possible.

  It also called for efforts to identify and apprehend the suspects still at large, and a thoroughinvestigation into the supply and sales chain of these inferior products.

  Although produced by licensed manufacturers, the quality of the vaccines are questionable as theywere not transported or stored properly.

(编辑:何莹莹)

版权及免责声明

凡本网注明"稿件来源:新东方"的所有文字、图片和音视频稿件,版权均属新东方教育科技集团(含本网和新东方网) 所有,任何媒体、网站或个人未经本网协议授权不得转载、链接、转贴或以其他任何方式复制、发表。已经本网协议授权的媒体、网站,在下载使用时必须注明"稿件来源:新东方",违者本网将依法追究法律责任。

本网未注明"稿件来源:新东方"的文/图等稿件均为转载稿,本网转载仅基于传递更多信息之目的,并不意味着赞同转载稿的观点或证实其内容的真实性。如其他媒体、网站或个人从本网下载使用,必须保留本网注明的"稿件来源",并自负版权等法律责任。如擅自篡改为"稿件来源:新东方",本网将依法追究法律责任。

如本网转载稿涉及版权等问题,请作者见稿后在两周内速来电与新东方网联系,电话:010-60908555。

热搜关键词